South Bend Indiana and San Francisco, California (PRWEB) November 15, 2013
GoInformatics (http://www.golims.com) and TeselaGen (http://www.teselagen.com) have announced a strategic partnership to offer a state-of-the-art Biological Design Automation and Scientific Data Management platform. With a secure repository to collect, organize, and store research information, the integrated cloud-based platform will enable scientists advance their research at a much faster pace. The cutting-edge biodesign automation tools will provide biologists the ability to engineer cells to more efficiently carry out desirable operations, such as producing medications and vaccines, better seeds and feed options, and converting plant material into high value chemicals and fuels.
Both TeselaGen and GoInformatics employ similar technology architectures that made the partnership a natural extension of each platform. GoInformatics will offer their GoLIMS platform as the infrastructure for research data collection and organization, intellectual property protection, and regulatory reporting. TeselaGen will offer its computer aided design and manufacturing platform for rapid prototyping biomolecules. The integration of GoInformatics LIMS with TeselaGen’s bioCAD/CAM platform will offer clients a comprehensive set of design, manufacturing and information management tools. Ultimately, the partnership provides researchers a cost-effective, premium cloud solution for R&D informatics.
“GoInformatics’ extensive experience in LIMS and ELN software solutions is a great pairing with our design automation solution,” said Michael Fero, CEO, TeselaGen. “Working with our customers in medical and industrial biotechnology, TeselaGen is building the IT backbone for the emerging field of synthetic biology. Through our close collaboration with industry, we have built a very economical R&D infrastructure that adds a great deal of real-world value. We think the time is ripe for all of biotech to take advantage of advanced cloud-based tools for their high-value R&D and research CRO management activities. Byte for Byte we generate some of the most valuable data in the world, encoding the next blockbuster drug or high value chemical. Having a LIMS partner like GoInformatics with a nearly identical technology stack will make integration and security provisioning a much easier proposition.”
“TeselaGen’s experience and capabilities in automated biomolecule design are of enormous value to our clients and prospects,” said Chad Gregory, CEO, GoInformatics. “We work closely with biotech companies in RNAi therapeutics, crop science, and animal health and nutrition space where TeselaGen’s bioCAD/CAM rapid prototyping tools can be of tremendous value. One of our key initiatives for this year was to find a strategic partner to complement our product and services and bring meaningful analytical biotechnology tools to our solution set. In TeselaGen, we found the ideal partner as both companies are very passionate about helping R&D organizations get more out of their spending and resources by implementing better scientific and technology infrastructures.”
GoInformatics is a privately held company based in South Bend, IN. The company provides Scientific Data Management tools and services for research and development groups. GoInformatics software solutions were built from the ground up as an exclusively cloud-based technology for research collaboration and organization, intellectual property protection, and regulatory compliance. Since its official launch, GoInformatics’ GoLIMS platform has been licensed and adopted by academic institutions and biotech companies around the world. The company’s tools have been implemented in Agrotech, Medical Devices, and Pharmaceutical institutions in the areas of discovery, development, and investigative research. http://www.golims.com/
TeselaGen is a synthetic biology platform, enabling the development of viral constructs, biologic medicines, and sustainably sourced chemicals. TeselaGen is privately held and is based in San Francisco, CA. Recently founded by three former Stanford fellows and housed at the QB3 incubator at UCSF, the company has received early recognition in the form of two US National Science Foundation grants, a US Department of Energy grant and a Bio-IT World Best Practices Award. TeselaGen uses its proprietary Synthetic Evolution® technology for efficient rapid prototyping of recombinant molecules. The company's customers that are helping validate its approach include: Amgen (USA), Genomatica (USA), and Redbiotec (Switzerland). http://www.teselagen.com